NHS: Drugs
Commons · Question 91858 · Tabled 17 Nov 2025 · Department of Health and Social Care · Official record
Answered 24 Nov 2025
Question
Asked by Jim Allister
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of high launch prices set by major pharmaceutical firms on NICE’s cost-effectiveness assessments; and what steps are being taken to prevent suc
Answer
Answered by Zubir Ahmed, 24 Nov 2025
The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost effectiveness. The NHS in England is lega...